The factors controlling the ability of human tumour cells to form colonies in soft agar are poorly understood. Clonogenic cells may respond to growth promoting or inhibiting substances produced by accessory cells. Selective manipulation and characterization of the different regulatory cell subsets are necessary to understand these complex interrelationships.
We have previously described the effect of phagocytic and adherent cells on the growth of human tumour colonies. We found that depletion of phagocytic macrophages from ovarian carcinoma effusions resulted in a decrease of tumour colonies (Hamburger et al., 1978) . In this case, tumour growth appeared to be macrophage-dependent. In an attempt to identify the macrophage subpopulations responsible for enhancing tumour growth, we depleted adherent cells of macrophages bearing surface Ia antigens and assessed the ability of the residual population to support growth (Hamburger & White, 1982) . The results indicated that Ia-macrophages enhanced the growth of tumour cells in soft agar and that Ta+ macrophages may have limited cell growth.
These observations were subsequently confirmed by Buick et al. (1980) using human malignant effusions derived from patients with a variety of adenocarcinomas and Schultz et al. (1980) using tumour cell lines and transplantable tumour systems. Similarly, Mantovani et al. (1979 Mantovani et al. ( , 1980 have demonstrated that macrophages from patients with ovarian cancer enhance the growth of ovarian tumour cells under defined conditions.
To further investigate the nature of potentiating cells, we determined the effect of irradiation on the ability of adherent cells to support tumour colony growth. The results indicate irradiation of adherent cells increased their ability to enhance the growth of human tumour colonies. The possibility that a radiosensitive T lymphocyte may have inhibited the growth of tumour colonies was also explored.
Materials and methods

Patients
Pleural or ascitic fluids (200-4,000 ml) were obtained aseptically in heparinized (10 units ml-1) vacuum bottles from patients with histologicallyproven epithelial neoplasms. The presence of tumour cells in the fluid was verified by an independent pathologist. Appropriate informed consent was obtained in all cases.
Cells
Fluid was passed through sterile gauze, centrifuged at 600g for 10min and the cell pellet resuspended in McCoy's 5A medium containing 10% foetal bovine serum (FBS). Cells were washed twice in this medium and counted in a haemocytometer. Viable nucleated cell counts (determined using erythrosin-B) were routinely >90%. Differential counts were performed on slides prepared with a cytocentrifuge and stained by the Papanicolaou (Luna, 1968) and Wright Giemsa methods and for nonspecific-esterase reactivity (Williams et al., 1977) .
Culture assays for colony forming cells (CFCs) Cells were cultured as described by Hamburger & Salmon (1977) . One ml underlayers, containing enriched McCoy's 5A medium in 0.5% agar were prepared in 35 mm plastic Petri dishes (Falcon 1008). Cells to be tested were suspended in 0.3% agar in enriched CMRL 1066 medium (GIBCO, Grand Island, N.Y.) with 15% horse serum (Sterile Systems, Logan, Utah). Each culture received 5 x 105 cells in 1 ml of agar-medium mixture. Cultures were incubated at 37°C in a 5% CO2 humidified incubator.
Scoring of cultures
Cultures were examined with a Zeiss inverted phase microscope at 100 and 160 x magnification. Colony counts of coded plates were made between 10 and 21 days after plating. Aggregates of > 30 light refractile cells were counted as colonies. The 0.3% agar layer, containing the colonies, was fixed and dried onto microscope slides as described by Salmon & Buick (1979) . Slides were stained with Papanicolaou stain for morphology and for nonspecific esterase, periodic-acid Schiff and mucicarmine reactivity (Luna, 1968 Treatment of adherent cells with monoclonal antibodies Adherent cells were resuspended at 106 cells in 1.0 ml McCoy's 5A medium supplemented with 10% FBS. The cell suspension was incubated with 1.0ml of antibody at an appropriate dilution at 4°C for 1 h, washed x 3 with HBSS and then incubated at 37°C for 45min with 1.0 ml of a 1:15 dilution of baby rabbit serum (Pelfrez, Rogers, AR) pretested for the absence of heterospecific antibodies as a source of complement (C). Cells were washed x 3 with HBSS, recounted, and cell kill assessed by vital dye staining. The appropriate number of treated cells was then added to the bottom layer in 35 mm culture dishes as described. The numbers of treated cells added were based on the original cell number present before antibody treatment. This was done to keep the number of antigen-negative cells constant in control and treated groups. Control cells were incubated with complement only.
Monoclonal antibodies
The OK panel of hybridoma monoclonal antibodies (OKT3, OKT4, OKT8) used in these studies were obtained from Ortho Pharmaceutical Corp., (Rartitan, NJ). In brief, the OKT3 antibody identifies a T cell antigen present on the majority of mature circulating T cells. The OKT4 antibody identifies the T-cell subset that provides helper/inducer function in T-T, T-B, and Tmacrophage interactions. The OKT8 antibody identifies the T-cell subset that provides cytotoxic suppressor function in these cell-cell interactions.
Another pan-T cell antibody, TIOI was used in the experiments (Hybritech Corp, La Jolla, CA). In all cases, the cytotoxic activity of each antibody was confirmed using 5"Cr release assay (Mishell & Shiigi, 1980) define the dose-dependence of the enhancing effect. Figure 1 demonstrates that as few as 2.5 Gy significantly increased the ability of adherent cells to support tumour colony growth. A maximal enhancement was reached between 5-0 Gy. Doses > 20 Gy slightly but significantly decreased the ability of adherent cells to support tumour colony growth.
Effect of depletion of adherent T-cells Although adherent cells usually consist of >90% macrophages (Buick et al., 1980; Hamburger & White, 1982) , variable numbers of lymphocytes were present in the adherent population (Table II) . We and others have demonstrated (Domagala et al., 1978; Haskill et al., 1982) that the majority of (Siegel & Siegel, 1977) and in the control of haematopoietic colony growth (Torok-Storb et al., 1981) We also investigated whether the irradiationinduced enhancement of tumour colony growth was dependent on the presence of T cells. Adherent cells were isolated as described and divided into two groups. One group was treated with the pan-T TIOI antibody. Half the cells in each group were subsequently irradiated. however, resulted in greatly increased colony formation.
Selective effect of irradiation on the ability of adherent cells to enhance colony formation We wished to demonstrate directly that the irradiation-induced augmentation of the ability of adherent cells to support tumour colony formation was due to a selective effect on T cells. We therefore isolated and selectively treated macrophages and lymphocytes. Adherent cells were isolated as described and depleted of T cells by Erosetting prior to irradiation. The cell populations were then reconstituted and assayed for their ability to support tumour colony formation. The results of one representative experiment (out of 4), using cells from a patient with ovarian cancer, are shown in Table V . Irradiation of macrophages alone did not increase the ability of adherent cells (macrophages and lymphocytes) to support tumour colony formation. By contrast, irradiation of lymphocytes alone increased the number of colonies to values observed when the reconstituted (irradiated macrophages and irradiated lymphocytes) were used. While T-cell depleted adherent cells could support growth, the enhanced ability of the irradiated macrophages to support growth was T cell dependent.
Discussion
The results of this study confirm our previous findings indicating that adherent and phagocytic cells are required for optimal in vitro tumour colony growth (Hamburger et al., 1978) . We now report that in 17/19 cases, irradiation enhanced the ability of adherent cells to support tumour colony formation. The irradiation induced enhancement may have been due to several factors. However, one of the more plausible explanations is that cells that suppress colony growth, either directly or indirectly, may have been inactivated.
Inactivation of radiosensitive (5-10Gy) lymphoid suppressor cells has been demonstrated in a number of immunological systems (Siegel & Siegel, 1977; Saiki & Ralph, 1982) . In most cases, the lymphoid cell is a T lymphocyte. This finding, plus the fact that the. majority of adherent lymphoid cells in effusions are T lymphocytes, (Haskill et al., 1982) led us to hypothesize that a major effect of irradiation was to inactivate a suppressor T lymphocyte. There is evidence that T cells may either directly suppress tumour growth (Gupta et al., 1978; Allavena et al., 1982) , or modulate secretion of cytostatic products of macrophages (Cameron & Churchill, 1979; Kleinerman, 1981) . Similarly, T cells modulate the ability of macrophages to produce acidic isoferritins that directly inhibit granulocyte-macrophage colony growth (Broxmeyer, 1981) .
Attempts were made to determine whether the potentiation of tumour colony growth by irradiation was mediated by T lymphocytes. This was most simply tested by rigorously eliminating T lymphocytes from the adherent cell population by antibody-mediated cytolysis and then determining whether antibody treatment or irradiation produced equivalent effects. The results indicate that depletion of T cells did not increase the colony stimulating ability of the adherent cells as much as did irradiation. However, we felt it was still likely that their irradiation effect was mediated by T lymphocytes. This was based on the fact that the ability of macrophages to secrete CSFs for haematopoietic colony forming cells is unaffected by irradiation (Williams et al., 1981) . We therefore postulated that treatment with the pan-T antibody eliminated both "suppressor" and "helper" subsets of T cells resulting in no overall change in tumour colony growth.
The existence of T lymphocytes that may augment secretion of CSFs for tumour cells was further supported by the finding that the increased stimulating activity of irradiated macrophages was found only when irradiated T cells were present. This indicates that the increased tumour colony enhancing activity of the macrophages was T cell dependent. This is reminiscent of the modulation of erythroid (Torok-Storb et al., 1982) and granulocyte (Bagby et al., 1982) colony formation in soft agar and tumour growth in vivo (Gabizon et al., 1980) that is dependent on T cell-macrophage collaboration.
We postulated that different subsets of T cells may be enhancing or limiting the growth of tumour colonies in collaboration with macrophages. The existence of easily separable subsets of T lymphocytes capable of either enhancing or inhibiting growth of transplantable animal tumours has been demonstrated (Small & Trainin, 1976; Blazar et al., 1978) . This hypothesis was directly tested by first treating the T cell population with either T4, T8 or T3 antibodies and C. These antibodies eliminate helper, suppressor, or all T cells respectively. The results of this study indicate that elimination of T4 helper subsets did not significantly decrease colony formation below that observed with untreated adherent cells. Growth was still significantly greater than that observed from nonadherent cells only. Treatment with T8 antibody resulted in increased levels of colonies above untreated controls, although the number of colonies was still somewhat lower than those observed with irradiation.
Further experiments in which either isolated T cells or macrophages were irradiated supported the hypothesis that the irradiation induced effect was via a T-lymphocyte. Irradiation of isolated macrophages alone did not enhance the ability of adherent cells (irradiated macrophages and untreated T lymphocytes in combination) to support tumour colony growth. In contrast, when irradiated T cells were added to untreated macrophages, increased colony formation over that observed in the presence of the reconstituted untreated macrophage-lymphocyte combination was observed.
Isolated T-depleted irradiated macrophages could support colony growth but the irradiation induced enhancement of colony growth was observed only when T cells were present. One interpretation of these findings is that a radiosensitive T cell may both inhibit tumour colony formation (directly or via macrophages) and also inhibit the production of growth enhancing factors by radioresistant T cells.
The results of these studies demonstrate that both adherent lymphocytes and macrophages can affect the growth of human tumour colonies in soft agar. Macrophages have been demonstrated to either enhance (Hamburger et al., 1978) or inhibit (Haskill et al., 1975) colony formation. Interacting subsets of T cells may modulate the ability of macrophages to produce colony stimulating or colony inhibiting factors. It is likely that individual patients can be characterized by a unique balance of tumour cell-accessory cell interactions at any time in the natural history of their disease. As the characterization of growth inhibiting or enhancing populations is limited by difficulties in obtaining and purifying adequate numbers of cells, future work should be directed towards obtaining and expanding these accessory cell populations.
The demonstration that manipulation of tumouraccessory cell interactions in vitro influences tumour cell growth may have implications for clinical treatment. The studies presented here are consistent with the hypothesis that many human tumours are to varying extents dependent on immune cells (Prehn, 1977) . Different subsets of macrophages and lymphocytes may have opposing effects on tumour cell survival and proliferation. In addition, the same populations that are stimulatory at low concentrations may be inhibitory at higher concentrations. Thus, alterations in either subset type, number, or activation state of immune cells by biological response modifiers or monoclonal antibodies may prove beneficial. Further proof that many human tumours are influenced by macrophage and lymphocytes may facilitate development of effective immunological approaches to therapy.
